PharmaGen

PharmaGen is a biotechnology company founded in 2009 and headquartered in Silver Spring, Maryland. The company is dedicated to empowering the future of medical and forensic science with integrated biotechnology solutions and expert support. PharmaGen specializes in molecular products and biotechnology services, including gene research and development. Their diverse product range encompasses diagnostic kits, reagents, laboratory equipment, and applications such as emetic fingerprinting for forensic and veterinary medicine. Additionally, PharmaGen provides technology transfer, laboratory installation, technical support services, and training courses for laboratory, clinical, and forensics professionals. The latest investment in PharmaGen was a $105.50K debt financing initiative on 04 September 2013. While details about the specific investors involved in this investment round are not provided, this funding injection is indicative of ongoing support and recognition of the company's potential in the biotechnology sector. PharmaGen's commitment to innovation and dedication to supporting medical and forensic advancement position it as a noteworthy player in the field of biotechnology.